Moreover, although these findings undeniably indicate the importance of SOX10 and MITF repression in tumorigenesis and therapy resistance (19), the mechanisms that sustain low levels of MITF and SOX10 in melanoma are not well understood, and the MITFlo melanoma subtypes in view of SOX10 expression have not yet been characterized. The gene discussed is SOX10; the disease is melanoma.